June 7, 2021
Dermavant Announces $200 Million of Financing
READ MORE
June 3, 2021
Dermavant Submits New Drug Application (NDA) to FDA for Tapinarof Cream for the Treatment of Adults with Plaque Psoriasis
READ MORE
May 6, 2021
Dermavant Announces Appointment of Michael Swartzburg as Chief Financial Officer
READ MORE
